AFWM
BMRN icon

Abich Financial Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Abich Financial Wealth Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$85.1K Buy
+1,571
New +$89.8K 0.03% 254
2024
Q3 		– Sell
-5
Closed -$412 – 433
2024
Q2 		$412 Buy
+5
New +$416 ﹤0.01% 724

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Abich Financial Wealth Management's BMRN Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2025: 1,571 shares worth $85.1K. The stake represents 0.03% of the portfolio and ranks #254 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in BMRN as recently as Q2 2024.

Abich Financial Wealth Management first reported a position in BMRN in Q2 2024 and has held it in 2 quarters since. 577 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Abich Financial Wealth Management held 1,571 shares of BioMarin Pharmaceuticals worth $85.1K as of Q3 2025.
  • BioMarin Pharmaceuticals was a new Abich Financial Wealth Management position in Q3 2025.
  • BioMarin Pharmaceuticals made up 0.03% of Abich Financial Wealth Management's portfolio in Q3 2025, its #254 holding.
  • Abich Financial Wealth Management first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 577 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.